Send feedback

CIAO2A

gene
On this page

Also known as FLJ22875CIA2A

Summary

CIAO2A (cytosolic iron-sulfur assembly component 2A, HGNC:26235) is a protein-coding gene on chromosome 15q22.31, encoding Cytosolic iron-sulfur assembly component 2A (Q9H5X1). Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. It is a selective cancer dependency (DepMap: 21.2% of cell lines).

Predicted to enable metal ion binding activity. Involved in iron-sulfur cluster assembly and protein maturation. Located in cytosol and nucleoplasm. Part of cytosolic [4Fe-4S] assembly targeting complex.

Source: NCBI Gene 84191 — automated summary from GO annotations (Alliance of Genome Resources).

At a glance

  • Clinical variants (ClinVar): 33 total
  • GTEx eGene: eQTL in 12 tissues, sQTL in 31 (q < 0.05)
  • Cancer dependency (DepMap): dependent in 21.2% of screened cell lines
  • Constraint (gnomAD): pLI 0.02 (LoF-tolerant), LOEUF 1.05 (unconstrained)
  • MANE Select transcript: NM_032231

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26235
Approved symbolCIAO2A
Namecytosolic iron-sulfur assembly component 2A
Location15q22.31
Locus typegene with protein product
StatusApproved
AliasesFLJ22875, CIA2A
Ensembl geneENSG00000166797
Ensembl biotypeprotein_coding
OMIM618382
Entrez84191

Gene structure

Transcript identifiers

Ensembl transcripts: 27 — 19 protein_coding, 8 nonsense_mediated_decay

MANE Select: ENST00000300030

Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 3, TSL 3: 1, TSL 5: 1

ENST00000300030, ENST00000380290, ENST00000557835, ENST00000558779, ENST00000559705, ENST00000559950, ENST00000851936, ENST00000851937, ENST00000851938, ENST00000927117, ENST00000927118, ENST00000927119, ENST00000977748, ENST00000977749, ENST00000977750, ENST00000977751, ENST00000977752, ENST00000977753, ENST00001065846, ENST00001065848, ENST00001065849, ENST00001065853, ENST00001102873, ENST00001102874, ENST00001102875, ENST00001102876, ENST00001132801

RefSeq mRNA: 3 — MANE Select: NM_032231 NM_001014812, NM_001289108, NM_032231

CCDS: CCDS10189, CCDS45278

Canonical transcript exons

ENST00000300030 — 5 exons

ExonStartEnd
ENSE000017242966407256564073028
ENSE000018656596409364564093838
ENSE000036152516407549264075537
ENSE000036385996408868764088851
ENSE000036663906408110264081151

Expression profiles

Bgee: expression breadth ubiquitous, 255 present calls, max score 99.11.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 86.1553 / max 610.0781, expressed in 1827 samples.

Highest expression (Bgee): ileal mucosa, lobe of liver, jejunal mucosa, ventricle myocardium, duodenum.

Genetic regulation across tissues (GTEx eQTL / sQTL)

CIAO2A is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 12 tissues and its splicing (sQTL) in 31 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.

showing 20 of 43 significant tissue × QTL associations:

TissueQTLq-valueSlopeLead variant
Thyroidsqtl2.6e-45-0.9515:64090212:G:A
Cells Cultured fibroblastssqtl9.1e-45-0.9215:64070537:CTT:C
Lungsqtl5.5e-28+0.8115:64108050:C:A
Artery Tibialsqtl1.6e-25-0.8015:64090212:G:A
Adipose Subcutaneoussqtl5.6e-24-0.7415:64060835:G:T
Adipose Visceral Omentumsqtl2.2e-23-0.7615:64090698:C:T
Breast Mammary Tissuesqtl3.4e-22+0.8915:64085036:G:GAGCCAAGAATGC
Nerve Tibialsqtl9.6e-21-0.7215:64090212:G:A
Esophagus Mucosasqtl1.3e-17-0.7515:64090830:G:A
Cells EBV-transformed lymphocyteseqtl2.7e-17-0.3015:64090212:G:A
Colon Sigmoidsqtl4.7e-16-0.7515:64090212:G:A
Artery Aortasqtl4.8e-16+0.7015:64117349:A:G
Stomachsqtl1.8e-15-0.7815:64063083:C:G
Pancreassqtl5.8e-15-0.8415:64090212:G:A
Esophagus Muscularissqtl7.9e-14-0.6515:64090212:G:A
Adrenal Glandsqtl1.5e-13-0.9515:64090212:G:A
Skin Not Sun Exposed Suprapubicsqtl5.0e-12+0.5515:64105977:G:A
Prostatesqtl5.0e-12+0.9215:64126198:G:A
Colon Transversesqtl1.3e-10-0.5515:64097544:C:T
Esophagus Gastroesophageal Junctionsqtl5.3e-10-0.7315:64090212:G:A

FANTOM5 promoters

3 alternative TSS:

Promoter IDTPM avgSamples expressed
15044864.19731826
15044915.93681784
1504506.02111577

Top tissues by expression

showing 100 of 256 tissues by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ileal mucosaUBERON:000033199.11gold quality
right lobe of liverUBERON:000111498.62gold quality
jejunal mucosaUBERON:000039998.56gold quality
left ventricle myocardiumUBERON:000656698.50gold quality
duodenumUBERON:000211498.12gold quality
jejunumUBERON:000211598.07gold quality
monocyteCL:000057698.05gold quality
kidney epitheliumUBERON:000481998.05gold quality
leukocyteCL:000073897.97gold quality
mucosa of transverse colonUBERON:000499197.95gold quality
right adrenal glandUBERON:000123397.66gold quality
metanephrosUBERON:000008197.62gold quality
mucosa of sigmoid colonUBERON:000499397.61gold quality
right adrenal gland cortexUBERON:003582797.61gold quality
colonic mucosaUBERON:000031797.60gold quality
palpebral conjunctivaUBERON:000181297.53gold quality
liverUBERON:000210797.52gold quality
pancreatic ductal cellCL:000207997.48gold quality
left adrenal glandUBERON:000123497.43gold quality
epithelium of nasopharynxUBERON:000195197.42gold quality
quadriceps femorisUBERON:000137797.38gold quality
lymph nodeUBERON:000002997.37gold quality
adrenal tissueUBERON:001830397.37gold quality
vastus lateralisUBERON:000137997.34gold quality
left adrenal gland cortexUBERON:003582597.31gold quality
myocardiumUBERON:000234997.27gold quality
adrenal cortexUBERON:000123597.22gold quality
rectumUBERON:000105297.07gold quality
deltoidUBERON:000147697.06gold quality
cortex of kidneyUBERON:000122597.05gold quality
tibialis anteriorUBERON:000138597.05gold quality
body of pancreasUBERON:000115097.04gold quality
hindlimb stylopod muscleUBERON:000425297.04gold quality
cardiac muscle of right atriumUBERON:000337997.01gold quality
thymusUBERON:000237096.99gold quality
metanephros cortexUBERON:001053396.88gold quality
left lobe of thyroid glandUBERON:000112096.84gold quality
adrenal glandUBERON:000236996.81gold quality
adult mammalian kidneyUBERON:000008296.77gold quality
right lobe of thyroid glandUBERON:000111996.71gold quality
renal medullaUBERON:000036296.64gold quality
amniotic fluidUBERON:000017396.61gold quality
thyroid glandUBERON:000204696.59gold quality
trabecular bone tissueUBERON:000248396.55gold quality
ventricular zoneUBERON:000305396.52gold quality
body of tongueUBERON:001187696.51gold quality
biceps brachiiUBERON:000150796.46gold quality
pigmented layer of retinaUBERON:000178296.42gold quality
adult organismUBERON:000702396.42gold quality
granulocyteCL:000009496.41gold quality
spleenUBERON:000210696.26gold quality
nasal cavity epitheliumUBERON:000538496.21gold quality
kidneyUBERON:000211396.19gold quality
placentaUBERON:000198796.13gold quality
heart right ventricleUBERON:000208096.08gold quality
heart left ventricleUBERON:000208496.05gold quality
cardiac ventricleUBERON:000208296.04gold quality
caecumUBERON:000115395.98gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450295.98gold quality
nasal cavity mucosaUBERON:000182695.95gold quality
epithelial cell of pancreasCL:000008395.89gold quality
vermiform appendixUBERON:000115495.89gold quality
bone marrowUBERON:000237195.89gold quality
germinal epithelium of ovaryUBERON:000130495.85gold quality
skeletal muscle tissueUBERON:000113495.81gold quality
tongueUBERON:000172395.81gold quality
olfactory segment of nasal mucosaUBERON:000538695.81gold quality
pancreasUBERON:000126495.80gold quality
ganglionic eminenceUBERON:000402395.77gold quality
synovial jointUBERON:000221795.75gold quality
lower lobe of lungUBERON:000894995.75gold quality
transverse colonUBERON:000115795.73gold quality
muscle of legUBERON:000138395.69gold quality
pylorusUBERON:000116695.63gold quality
muscle tissueUBERON:000238595.59gold quality
oral cavityUBERON:000016795.58gold quality
small intestine Peyer’s patchUBERON:000345495.49gold quality
gastrocnemiusUBERON:000138895.43gold quality
superior surface of tongueUBERON:000737195.42gold quality
heartUBERON:000094895.29gold quality
gall bladderUBERON:000211095.29gold quality
endometriumUBERON:000129595.22gold quality
penisUBERON:000098995.21gold quality
small intestineUBERON:000210895.21gold quality
prostate glandUBERON:000236795.18gold quality
tibiaUBERON:000097995.17gold quality
C1 segment of cervical spinal cordUBERON:000646995.14gold quality
cardiac atriumUBERON:000208195.02gold quality
right atrium auricular regionUBERON:000663194.90gold quality
spinal cordUBERON:000224094.87gold quality
parietal pleuraUBERON:000240094.84gold quality
body of stomachUBERON:000116194.83gold quality
intestineUBERON:000016094.73gold quality
bronchial epithelial cellCL:000232894.58gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451194.58gold quality
large intestineUBERON:000005994.52gold quality
cardia of stomachUBERON:000116294.46gold quality
apex of heartUBERON:000209894.45gold quality
bronchusUBERON:000218594.44gold quality
epithelium of mammary glandUBERON:000324494.39gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-81383no283.68
E-MTAB-5061no3.22
E-ANND-3no0.00

HPA expression

RNA tissue specificity: Tissue enhanced

showing 60 of 80 HPA tissues / cells by nTPM:

Tissue / cellAxisnTPMProtein (IHC)
Livertissue245.2low
Skeletal muscletissue117.7medium
Duodenumtissue101.4medium
Lymph nodetissue98.3not detected
Tonguetissue90.9
Small intestinetissue81.7medium
Colontissue77.5medium
Kidneytissue75.8medium
Thyroid glandtissue75.0medium
Heart muscletissue73.0low
Parathyroid glandtissue70.8medium
Bone marrowtissue66.7not detected
Stomach 1tissue64.8high
Rectumtissue64.2medium
Tonsiltissue62.6not detected
Placentatissue61.5medium
Corpus callosumtissue60.9
Choroid plexustissue57.3
Pancreastissue56.3medium
Thymustissue56.2
Adrenal glandtissue55.2medium
Appendixtissue50.6medium
Spinal cordtissue49.9
Spleentissue49.7not detected
Midbraintissue47.0
Medulla oblongatatissue46.4
Thalamustissue46.2
Breasttissue45.4medium
Ponstissue44.3
Substantia nigratissue44.2
Urinary bladdertissue43.3low
Putamentissue41.7
Salivary glandtissue41.4medium
Lungtissue40.9medium
Superior colliculitissue40.8
Gallbladdertissue40.3medium
Epididymistissue38.8low
Periaqueductal graytissue38.2
Caudate putamentissue37.6
Prostatetissue36.7not detected
Frontal cortextissue35.9
Septumtissue35.0
Ventral forebraintissue34.9
Hypothalamustissue34.3
Hippocampal formationtissue30.4
Fallopian tubetissue30.2medium
Cervixtissue29.6medium
Basal gangliatissue28.5low
Esophagustissue28.0low
Cerebral cortextissue27.2medium
Somatosensory cortextissue27.2
Motor cortextissue27.1
Ovarytissue26.8not detected
Occipital cortextissue26.6
Adipose tissuetissue26.1low
Amygdalatissue26.1
Pituitary glandtissue26.0
Seminal vesicletissue25.3low
Retrosplenial cortextissue24.4
Olfactory bulbtissue24.3

Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — White matter (60.9), Ventral spinal cord (49.9), Dorsal spinal cord (44.8), Corpus callosum, splenium (white matter) (40.8), Lateral funiculus (white matter) (37.3).

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

Targeting CIAO2A by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).

showing 30 of 42 miRNAs:

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-3120-5P100.0065.56965
HSA-MIR-450099.9972.722367
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-569699.9872.364487
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-381-3P99.9371.872854
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-30099.9271.762856
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-806799.8669.592260
HSA-MIR-120099.7170.421838
HSA-MIR-425199.4069.193363
HSA-MIR-4797-5P99.3968.011354
HSA-MIR-2115-3P99.3169.682026
HSA-MIR-6719-3P99.2967.781387
HSA-MIR-580-5P99.2870.941776
HSA-MIR-593-3P99.2267.281327
HSA-MIR-544B99.1867.411632
HSA-MIR-432499.0470.141569
HSA-MIR-4711-5P98.8968.00965
HSA-MIR-76098.8166.651392
HSA-MIR-501-5P98.7768.881328

Functional genomics

gnomAD constraint: pLI 0.0232, LOEUF 1.05, missense Z 0.127 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD

Regional missense constraint (gnomAD RMC): no regional variation along ENST00000300030 — one region, missense o/e 1.00. DepMap (CRISPR cell-line fitness): dependent in 21.2% of screened cell lines.

Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): NCI-H1573 (-1.399), HCC-33 (-1.31), LN-340 (-1.148), HT-144_DAB_R (-1.123), JVE-015 (-1.065), SNU-620 (-1.05), SNU-1544 (-1.043), HT-144_DAB_ROX_R (-1.04), SUM-149PT (-1.03), KKU-100 (-1.021), HuNS1 (-1.016), Mero-14 (-1.01), JHUEM-1 (-1.004), C84 (-1.002), MUTZ-8 (-0.958).

Literature-anchored findings (GeneRIF, showing 5)

  • putative metal-binding site of bacterial DUF59 proteins is not conserved in Fam96a, but Fam96a interacts tightly in vitro with Ciao1, the cytosolic iron-assembly protein (PMID:22683786)
  • CIA2B-CIA1-MMS19 and CIA2A-CIA1 assist different branches of Fe/S protein assembly and intimately link this process to cellular iron regulation via IRP1 Fe/S cluster maturation and IRP2 stabilization. (PMID:23891004)
  • FAM96A expression was much reduced in tumorigenic ICC-SCs. (PMID:25716227)
  • our data suggest that hTERTR-FAM96A may serve as an efficient anti-tumor agent for the treatment of hepatocellular carcinoma. (PMID:28443470)
  • FAM96A suppresses epithelial-mesenchymal transition and tumor metastasis by inhibiting TGFbeta1 signals. (PMID:35513087)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriociao2aENSDARG00000104940
mus_musculusCiao2aENSMUSG00000032381
rattus_norvegicusCiao2aENSRNOG00000017119
drosophila_melanogastergalla-1FBGN0034543

Paralogs (1): CIAO2B (ENSG00000166595)

Mouse-model phenotypes

Observed phenotypes of the mouse ortholog (MGI:1915500) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.

Mouse phenotype (MP)Records
decreased erythrocyte cell number1

Additional cross-species homologs

Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.

OrganismUniProtIdentityMethod
Bos taurusQ3T0U796.9%Diamond
Schizosaccharomyces pombe 972h-Q9UTL061.2%Diamond
Dictyostelium discoideumQ54QK160.9%Diamond
Arabidopsis thalianaQ9C9G660.5%Diamond
Caenorhabditis elegansO6225260.3%Diamond
Saccharomyces cerevisiae S288CP3882955.5%Diamond

Genomic neighbors (locus context)

Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).

SymbolTypeEntrez
DAPK2protein-coding23604
MIR422AncRNA494334
SNX1protein-coding6642
HERC1protein-coding8925
CSNK1G1protein-coding53944
PPIBprotein-coding5479
SNX22protein-coding79856
USP3-AS1ncRNA100130855
FBXL22protein-coding283807
PCLAFprotein-coding9768

Protein

Protein identifiers

Cytosolic iron-sulfur assembly component 2A — Q9H5X1 (reviewed: Q9H5X1)

Alternative names: MIP18 family protein FAM96A

All UniProt accessions (4): Q9H5X1, A0AAQ5BII0, H0YKV4, H0YLH6

UniProt curated annotations — full annotation on UniProt →

Function. Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. As a CIA complex component and in collaboration with CIAO1 specifically matures ACO1 and stabilizes IREB2, connecting cytosolic iron-sulfur protein maturation with cellular iron regulation. May play a role in chromosome segregation through establishment of sister chromatid cohesion. May induce apoptosis in collaboration with APAF1.

Subunit / interactions. Monomer and homodimer. Component of the CIA complex. Interacts with CIAO1. Interacts with IREB2. Interacts with APAF1.

Subcellular location. Cytoplasm.

Tissue specificity. Substantially enriched in macrophages.

Similarity. Belongs to the MIP18 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9H5X1-11yes
Q9H5X1-22

RefSeq proteins (3): NP_001014812, NP_001276037, NP_115607* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002744MIP18-likeDomain
IPR034904FSCA_dom_sfHomologous_superfamily
IPR039796MIP18Family

Pfam: PF01883

UniProt features (23 total): binding site 8, helix 6, strand 6, chain 1, turn 1, splice variant 1

Structure

Experimental structures (PDB)

3 structures by resolution:

PDBTitleMethodResolution (Å)
3UX2Crystal Structure of Domain-Swapped Fam96a Major dimerX-RAY DIFFRACTION1.8
3UX3Crystal Structure of Domain-Swapped Fam96a minor dimerX-RAY DIFFRACTION1.8
2M5HNMR structure note: solution structure of monomeric human FAM96ASOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H5X1-F186.900.69

Human Protein Atlas

Protein class: Predicted intracellular proteins

Protein evidence: Evidence at protein level

Subcellular location (HPA, imaging): cytosol; nucleoplasm

Antibody reliability (HPA): IH approved · IF enhanced

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (8)

PositionRole
89Zn(2+)
123Zn(2+)
150Zn(2+)
153Zn(2+)

Function

Pathways and Gene Ontology

Reactome pathways

0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).

MSigDB gene sets: 163 (showing top): MODULE_151, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, TGACCTY_ERR1_Q2, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_PROTEIN_MATURATION, GATA6_01, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13, DODD_NASOPHARYNGEAL_CARCINOMA_UP, RYTTCCTG_ETS2_B, MODULE_568, MODULE_491, MODULE_114, AACATTC_MIR4093P, GOBP_CELL_CYCLE_PROCESS

GO Biological Process (3): chromosome segregation (GO:0007059), iron-sulfur cluster assembly (GO:0016226), protein maturation (GO:0051604)

GO Molecular Function (2): metal ion binding (GO:0046872), protein binding (GO:0005515)

GO Cellular Component (4): nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829), cytosolic [4Fe-4S] assembly targeting complex (GO:0097361)

GO top-level categories

12 GO namespaces:

CategoryTerms
cellular anatomical structure3
cell cycle process1
metallo-sulfur cluster assembly1
gene expression1
protein metabolic process1
cation binding1
binding1
nuclear lumen1
intracellular anatomical structure1
cytoplasm1
intracellular protein-containing complex1
iron-sulfur cluster assembly complex1

Experimentally-supported GO annotations

GO terms backed by direct experimental evidence (ECO experimental codes) — 5 of 9 annotations. The rest are phylogenetic / computational / electronic (IEA).

5 experimentally-supported GO terms:

GO termNSEvidence
iron-sulfur cluster assemblyBPdirect assay
protein maturationBPmutant phenotype
cytosolCCdirect assay
cytosolic [4Fe-4S] assembly targeting complexCCdirect assay
nucleoplasmCCdirect assay

Protein interactions and networks

STRING

showing 15 of 622 interactions by confidence (×1000):

Protein AProtein BPartner UniProtScore
CIAO2ACIAO1O76071783
CIAO2AMMS19Q96T76717
CIAO2ACIAO3Q9H6Q4656
CIAO2ANUBP1P53384605
CIAO2ACIAPIN1Q6FI81572
CIAO2AABCB7O75027516
CIAO2AGLRX3O76003504
CIAO2AQNG1Q5T6V5481
CIAO2AISCA1Q9BUE6466
CIAO2ACYB561P49447461
CIAO2AFBXL5Q9UKA1453
CIAO2AIREB2P48200430
CIAO2ANDOR1Q9UHB4426
CIAO2ASLC25A28Q96A46407
CIAO2ASLC25A37Q9NYZ2405

IntAct

Human interaction partners of CIAO2A in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).

25 partners by confidence:

PartnerInteraction typeMIscoreRecords
CIAO1physical association0.95017
TMED8physical association0.5606
CREB3L1physical association0.5605
APOA2physical association0.5603
CMTM6physical association0.5603
DERL1physical association0.5603
DGAT2L6physical association0.5603
EBAG9physical association0.5603
ERGIC3physical association0.5603
FKBP7physical association0.5603
GJA8physical association0.5603
GSC2physical association0.5603
KCNIP1physical association0.5603
LIME1physical association0.5603
MESTphysical association0.5603
PLP2physical association0.5603
PLPP6physical association0.5603
PLPPR2physical association0.5603
PRAF2physical association0.5603
RHBDD2physical association0.5603
SETD4physical association0.5603
SIN3Aphysical association0.5603
TNFRSF10Dphysical association0.5603
VAMP3physical association0.5603
MAP2K7association0.3501

SIGNOR signaling

1 signaling interactions:

AEffectBMechanism
CIAO2A“form complex”“CIAO1-CIAO2A-CIAO3 cytosolic iron-sulfur protein assembly complex”binding

Disease & clinical

Genetic variants

Variant evidence for CIAO2A: 33 ClinVar records (0 pathogenic / likely pathogenic).

ClinVar

33 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance25
Likely benign0
Benign0

SpliceAI

Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 36 predictions of 340):

Position(s)EffectΔscoreSites
15:64075545acceptor_gain1.0000
15:64088685–64088686donor_loss1.00005
15:64093643–64093644donor_loss1.00004
15:64073029–64073030acceptor_loss0.99006
15:64075538–64075539acceptor_loss0.99005
15:64088852–64088853acceptor_gain0.99006
15:64093644donor_loss0.9900
15:64093663donor_gain0.9900
15:64073036acceptor_loss0.9800
15:64075490–64075491donor_loss0.98006

AlphaMissense

507 missense substitutions predicted likely pathogenic (of 1,027 scored), across 108 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:

ResidueLikely-pathogenic substitutionsMean am_pathogenicityMax am_pathogenicity
D13581.0001.000
D4980.9981.000
H12380.9950.999
N14580.9790.997
F8380.9540.999
H8980.9470.992
D4280.8910.967
D12880.8310.982
C9070.9991.000
E13770.9980.999
E5170.9940.998
E14470.9900.998
Q13270.9870.999
N13470.9760.996
K13670.9721.000
C15570.9640.997
I9670.9490.999
N13070.9420.997
C9970.9290.999
E5770.8870.987

HPA cancer prognostics

RNA cancer specificity: Low cancer specificity

Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.

2 prognostic cancer types:

CancerPrognosticp-value
Kidney Renal Clear Cell Carcinoma (TCGA)favorable1.59e-06
Prostate Adenocarcinoma (TCGA)unfavorable0.000925

Disease associations

OMIM: gene MIM:618382 | disease phenotypes:

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4295943 (SINGLE PROTEIN)

PharmGKB: 1 entry (CPIC guideline: no)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, affects cotreatment, increases abundance, increases expression3
Cadmiumdecreases expression2
Cyclosporinedecreases expression2
perfluorodecanesulfonic acidincreases expression1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
bisphenol Aincreases expression1
arseniteaffects binding, increases reaction1
perfluorooctanoic acidincreases expression1
manganese chlorideincreases expression, affects cotreatment, increases abundance1
perfluorooctane sulfonic acidincreases expression1
K 7174decreases expression1
perfluorobutanesulfonic acidincreases expression1
Acetaminophendecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Antimycin Adecreases expression1
Arsenicincreases abundance, increases expression, affects cotreatment1
Cisplatinincreases expression1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Doxorubicinincreases expression1
Ivermectindecreases expression1
Manganeseincreases abundance, increases expression, affects cotreatment1
Rotenonedecreases expression1
Urethanedecreases expression1
Aflatoxin B1decreases methylation1
Antirheumatic Agentsdecreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1
Particulate Matterdecreases expression, increases abundance1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4118609BindingBinding affinity to FAM96A in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assayStudies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — *Bioorg Med Chem*

Clinical trials (associated diseases)

Via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.